CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Mirna Therapeutics, Inc.  (MIRN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Mirna Therapeutics's Quick Ratio

MIRN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

MIRN Quick Ratio (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Current Liabilities Change -70.06 % -90.21 % -76.87 % - -
Y / Y Cash & cash equivalent Change -28.61 % -32.56 % 85.58 % - -
Quick Ratio MRQ 155.06 167.58 57.47 49.63 65.04
Overall Ranking # 28 # 35 # 57 # 60 # 56
Seq. Current Liabilities Change 2.77 % -68.69 % -21.14 % 18 % -66.4 %
Seq. Cash & cash equivalent Change -4.91 % -8.69 % -8.68 % -9.97 % -10.17 %



Quick Ratio first quarter 2017 Comment
Due to increase in Current Liabilities in the first quarter 2017, Quick Ratio fell to 155.06 below Mirna Therapeutics, Inc. average.

Within Biotechnology & Drugs industry Mirna Therapeutics, Inc. achieved highest Quick Ratio than Mirna Therapeutics in first quarter 2017. While Quick Ratio total ranking has improved so far to 28, from total ranking in previous quarter at 35.

Explain Quick Ratio?
What are MIRN Segments?
See Quick Ratio MIRN on the trailing twelve month basis
Quick Ratio first quarter 2017 Company Ranking
Within: No.
Industry # 1
Sector # 1
S&P 500 # 28


Quick Ratio Statistics
High Average Low
167.58 75.18 7.16
(Dec 31 2016)   (Sep 30 2015)


You need to upgrade your Flash Player


Financial Statements
Mirna Therapeutics's Current Liabilities $ 0 Millions Visit MIRN's Balance sheet
Mirna Therapeutics's Cash & cash equivalent $ 58 Millions Visit MIRN's Balance sheet
Source of MIRN's Sales Visit MIRN's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2017, within Biotechnology & Drugs Industry Quick RatioMar 31 2017 MRQ Cash & cash equivalentMar 31 2017 MRQ Current Liabilities
Mirna Therapeutics, Inc.  155.06 $ 57.529  Millions$ 0.371  Millions
Adverum Biotechnologies, Inc.  39.26 $ 209.503  Millions$ 5.336  Millions
Regenxbio Inc.  35.31 $ 145.809  Millions$ 4.129  Millions
Kubota Pharmaceutical Holdings Co Ltd  34.17 $ 114.410  Millions$ 3.348  Millions
Gtx Inc  32.12 $ 16.511  Millions$ 0.514  Millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com